Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Big bigCover of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

More books from Springer US

bigCover of the book Diagnosis and Treatment Planning in Counseling by

bigCover of the book Handbook of Community Psychology by

bigCover of the book The Socialization of Emotions by

bigCover of the book Bacterial Diversity and Systematics by

bigCover of the book Fiscal responsibility in constitutional democracy by

bigCover of the book Evolving Concepts in Sepsis and Septic Shock by

bigCover of the book Severe Learning Disabilities and Challenging Behaviours by

bigCover of the book Aging, Carcinogenesis, and Radiation Biology by

bigCover of the book Cell-Mediated Effects of Immunoglobulins by

bigCover of the book Challenging Mathematics In and Beyond the Classroom by

bigCover of the book Social Influence Processes and Prevention by

bigCover of the book Angina Pectoris with Normal Coronary Arteries: Syndrome X by

bigCover of the book ELF and VLF Electromagnetic Field Effects by

bigCover of the book Ultrasound in Medicine by

We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy